Bank of Queensland Ltd (ASX: BOQ), Telix Pharmaceuticals Ltd (ASX: TLX), and NextDC Ltd (ASX: NXT) shares are grabbing headlines today.
In late morning trade on Tuesday, all three blue-chip stocks are racing ahead of the 2.6% intraday gains posted by the S&P/ASX 200 Index (ASX: XJO).
Here's what's happening.
Image source: Getty Images
NextDC shares leap on $1 billion funding news
Turning to NextDC first, shares in the ASX 200 data centre operator and developer are up 13.6% today, trading for $12.79 apiece.
Investors are sending NextDC shares surging after the company announced it was raising $1 billion in new funds via the issue of new hybrid securities.
The hybrid securities launch is backed by Canadian investment group La Caisse, which inked a binding $1 billion commitment to make up for any potential shortfall.
The securities carry a 100-year maturity.
The new funds will support NextDC's plans to develop new data centres and expand capacity.
Commenting on the fund-raising initiative that's boosting NextDC shares today, CEO Craig Scroggie said:
The announcement of the Hybrid Securities Offer and the La Caisse commitment represent another step toward NextDC delivering on a material step-change in the scale of our business as we deliver on the company's contracted forward order book across the period to FY29 and make further investments across the portfolio of new projects.
Which brings us to…
Telix shares surge on revenue growth
Telix shares are also catching plenty of investor attention today.
Shares in the ASX 200 diagnostic and therapeutic product developer are up 6.3% today, trading for $13.77 each.
This follows the release of Telix's March quarterly update.
Among the highlights, the company reported an 11% quarter-on-quarter increase in unaudited revenue to US$230 million. And management reaffirmed full-year FY 2026 revenue guidance in the range of US$950 million to US$970 million.
The March quarter saw the ASX healthcare share continue to advance its global studies across prostate, brain, and kidney cancer.
"We are delivering on our strategic priorities to advance our high-value clinical programs, demonstrated by the momentum in our therapeutics pipeline this quarter," Telix CEO Christian Behrenbruch said.
Bank of Queensland shares jump on strategic loan sale
Last, but not least, Bank of Queensland shares join Telix and NextDC shares in grabbing financial headlines and outperforming today.
Shares in the ASX 200 bank stock are up 5.3% at the time of writing, changing hands for $7.16 each.
Investors are bidding up Bank of Queensland shares after the company reported on its $3.7 billion equipment finance loan sale to investment management firm Challenger Ltd (ASX: CGF).
Why is this boosting the Bank of Queensland share price today?
As the Motley Fool reported this morning:
The capital partnership enables BOQ to accelerate its specialist banking transformation by shifting equipment finance exposures off balance sheet while growing capital-light revenues. The transition is designed to improve return on equity and support further business in the small and medium business sector.
